Susquehanna Fundamental Investments’s Solid Biosciences SLDB Stock Holding History

Susquehanna Fundamental Investments’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$333K	Buy	+33,291	New	+$252K	0.01%	636
2026 Q1	–	Sell	-116,525	Closed	-$657K	–	668
2025 Q4	$657K	Hold	116,525	–	–	0.02%	395
2025 Q3	$719K	Sell	116,525 -25,027	-18%	-$146K	0.03%	385
2025 Q2	$689K	Hold	141,552	–	–	0.02%	506
2025 Q1	$524K	Buy	+141,552	New	+$606K	0.01%	832
2024 Q2	$91.9K	Buy	+16,200	New	+$145K	﹤0.01%	901
2021 Q4	–	Sell	-2,857	Closed	-$102K	–	1734
2021 Q3	$102K	Buy	2,857 +1,585	+125%	+$67.3K	﹤0.01%	1619
2021 Q2	$70K	Sell	1,272 -228	-15%	-$15.1K	﹤0.01%	1601
2021 Q1	$124K	Buy	1,500 +353	+31%	+$39.1K	﹤0.01%	1448
2020 Q4	$130K	Buy	+1,147	New	+$72.5K	﹤0.01%	1399

Other funds holding SLDB

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Susquehanna Fundamental Investments's SLDB Position: Q2 2026 in Review

Susquehanna Fundamental Investments opened a new position in Solid Biosciences (SLDB) in Q2 2026: 33,291 shares worth $333K. The stake represents 0.01% of the portfolio and ranks #636 among its holdings. This is a return to the name: Susquehanna Fundamental Investments previously reported a position in SLDB as recently as Q4 2025.

Susquehanna Fundamental Investments first reported a position in SLDB in Q4 2020 and has held it in 10 quarters since. The position peaked at $719K in Q3 2025. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

Susquehanna Fundamental Investments held 33,291 shares of Solid Biosciences worth $333K as of Q2 2026.
Solid Biosciences was a new Susquehanna Fundamental Investments position in Q2 2026.
Solid Biosciences made up 0.01% of Susquehanna Fundamental Investments's portfolio in Q2 2026, its #636 holding.
Susquehanna Fundamental Investments first reported a position in Solid Biosciences in Q4 2020 and has held it in 10 quarters since.
Susquehanna Fundamental Investments's Solid Biosciences position peaked at $719K in Q3 2025.
157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2026, filed 14 Aug 2026.